Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof

Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof

US Patent 5399565 · Granted Mar 21, 1995

Estimated economic value: $33,211,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of organophosphate exposure with triptans2020
Emesis treatment2020
Treatment of organophosphate exposure with ocinaplon2019
Use of cyproheptadine to treat organophosphate exposure2019
Emesis treatment2019
Emesis treatment2018
Toll-like receptor agonist formulations and their use2015
Methods for treating cognitive/attention deficit disorders using tetrahydroindol2014
Assay for determination of compounds having anti-emetic activity2014
Tetrahydroindolone derivatives for treatment of neurological conditions2013
Methods for treating cognitive/attention deficit disorders using tetrahydroindol2013
Methods of synthesis of benzazepine derivatives2012